Abion

Therapeutics for cancer and auto-immune diseases.

placeSeoul, Seoul, South Korea calendar_todayFounded 2007 groups33 employees language abionbio.com

Registered entities

Innovation

48 patent families (20 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 982 times.

YearFilings
20151
201610
20177
201814
201910
202012
202115
202214
202314
202419
202510
20262

Investor mix

10 investors on record; lead investors include Korea Investment Holdings.

Investor typeCountShare
Venture capital550%
Private equity220%
Bank & private debt110%
Other / undisclosed220%
Coming soon